Drugs and Nutritional Supplements in the Therapy of Interstitial Pneumonia Complications in Post-COVID Fibrosis

Read full text
Authors: Maria Sevdelinova Chaneva, Petar Atanasov, Danka Petrova Obreshkova, Valentin Dimitrov, Christo T. Tzachev, Adel Ibrahim, Stefka Ivanova
Cited by: 0

Abstract

Increased collagen synthesis is the cause of the disease fibrosis. Factors contributing to the development of fibrosis include chronic inflammation, infections, oxidative stress, autoimmune diseases, physical injuries, surgical procedures, long-term exposure to toxins, radiation therapy. Types of fibrosis are pulmonary, cardiac, renal, hepatic, intestinal, skin, skeletal muscle fibrosis. The aim of current study is the estimation of the potential beneficial effect of drugs and nutritional supplements in the therapy of Interstitial Pneumonia complication in Post-COVID Fibrosis. The beneficial effect is shown of application of enzyme therapy using the product Fibrozim including the enzymes Serrazime and Bromelain and antioxidants Quercetin and Curcumin.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Long-Term Effects of COVID-19 COVID-19 Clinical Research Studies

Publication details

Journal / source
Scholars Academic Journal of Pharmacy
Volume
15
Issue
01
Pages
25–31
Publication date
31 January 2026
Language
EN